Cisplatin or carboplatin for the treatment of non-small cell lung cancer: do they have equivalent efficacy?

Lung Cancer. 2001 Oct;34(1):15-7. doi: 10.1016/s0169-5002(01)00240-9.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carboplatin / administration & dosage
  • Carboplatin / pharmacokinetics*
  • Carboplatin / pharmacology
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / pathology
  • Cisplatin / administration & dosage
  • Cisplatin / pharmacokinetics*
  • Cisplatin / pharmacology
  • Clinical Trials as Topic
  • Endpoint Determination
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Research Design
  • Survival Analysis
  • Therapeutic Equivalency

Substances

  • Carboplatin
  • Cisplatin